Figure 7
SOV strengthens sorafenib in suppressing sorafenib-resistant tumors in vivo. (a) Animal experimental schedule was described in Materials and Methods. (b) The bodyweights of mice were monitored. (c) The size (mm3) of tumors was recorded. (d) Tumors harvested at the end of experiments were weighed and representative tumors photographed. “*” Indicates P < 0.05, and “**” P < 0.001.
